Feedback systems for the quality of chest compressions during cardiopulmonary resuscitation

167 p.Se define la parada cardiorrespiratoria como la detención súbita de la actividad mecánica del corazón, confirmada por la ausencia de signos de circulación. En caso de parada cardiorrespiratoria, dos actuaciones son clave para la supervivencia del paciente: la reanimación cardiopulmonar (RCP) precoz, y la desfibrilación precoz. La RCP consiste en proporcionar compresiones torácicas y ventilaciones al paciente para mantener un mínimo flujo de sangre oxigenada a los órganos vitales. La calidad de las compresiones está relacionada con la supervivencia del paciente. Por esta razón las guías de resucitación recomiendan el uso de sistemas de feedback que monitorizan la calidad de la RCP en tiempo real. Estos dispositivos se sitúan generalmente entre el pecho del paciente y las manos del rescatador, y guían al rescatador para ayudarle a alcanzar la profundidad y frecuencia de compresión objetivo. Esta tesis explora nuevas alternativas para monitorizar la calidad de las compresiones durante la RCP. Se han seguido dos estrategias: usar la señal de impedancia transtorácica (ITT), que es adquirida por los desfibriladores actuales a través de los parches de desfibrilación, y usar la aceleración del pecho, que podría ser registrada usando un dispositivo adicional

Automated Cardiac Rhythm Diagnosis for Electrophysiological Studies, an Enhanced Classifier Approach

INTRODUCTION Heart function can be impaired by rhythm disturbances (cardiac arrhythmia), illustrated by electrocardiogram (ECG) recordings. Computerised arrhythmia diagnosis is well established for ECG’s but less for intracardiac electrophysiological (EP) testing. Accurate diagnosis is pre-requisite for delivering appropriate treatment to patients however existing algorithms misdiagnose a proportion of arrhythmias. Studies suggested artificial intelligence (AI) classifiers are accurate using ECG and intracardiac electrogram features and reviews suggested new features might augment diagnosis. This study aimed to develop an accurate cardiac rhythm diagnostic algorithm for electrophysiological (EP) studies with potential application as a generic rhythm classifier. METHOD An ethically approved prospective clinical study collected clinical history, right atrial and right ventricular intracardiac electrograms, beat-to-beat cardiac stroke volume, body motion and body temperature data during EP studies. An iterative system development life-cycle was used, including knowledge management and classifier development sub-processes. Domain expert knowledge and clinical arrhythmia diagnosis were modelled, synthesised as AI classifiers and used to classify cardiac rhythms. RESULTS Data collected from 65 patients was pre-processed into instances for classifier inputs. Decision tree, naïve Bayes, neural network, support vector machine and inference engine classifiers developed using Matlab showed good performance and were combined as a production system in a mixture-of-experts multi-classifier system. 18 different rhythms were classified, with the naïve Bayes classifier used to classify 11 rhythms, decision tree 4 rhythms, neural network and support vector machine one each, unclassified instances by the inference engine classifier and final class allocation using decision rule. Production system showed overall correct clasification rate 0.960; error 0.040; mean sensitivity 0.855; mean specificity 0.977; mean κ 0.767; mean positive predictive value 0.792; mean negative predictive value 0.975; mean Pearson’s phi 0.787, with P 0.9 for sinus node dysfunction and atrio-ventricular nodal/ junctional tachycardias. Temperature, accelerometry and QT interval were assessed as features by a comparison of algorithm performances with each feature removed and found not to affect classification performance. An evaluation showed 10 beat analysis performed better than 5 beat analysis. CONCLUSIONS Modelling of the clinical diagnosis process produced an AI based mixture-of-experts multi-classifier system, which accurately diagnosed different 18 cardiac rhythms. The naïve Bayes classifier performed best and classified 11 rhythms. Features for clinical symptoms and predisposing factors, atrial electrogram morphology and changes in stroke volume were found to influence rhythm classification. High performances encourage further development and potential future improvements include: a larger sample dataset; inclusion of His and coronary sinus electrograms; data mining for unknown features with significant influence on diagnosis; binary classification. The aim to classify rhythm using artificial intelligence suitable for use during EP studies was satisfied and the research hypothesis that it outperformed current algorithms was accepted. The system was likely to be able to accept updates but needs conversion as a precursor to use in a live clinical environment

Advanced bioimpedance signal processing techniques for hemodynamic monitoring during anesthesia

Cardiac output (CO) defines the blood flow arriving from the heart to the different organs in the body and it is thus a primary determinant of global 02 transport. Cardiac output has traditionally been measured using invasive methods, whose risk sometimes exceeds the advantages of a cardiac output monitoring. In this context, the minimization of risk in new noninvasive technologies for CO monitoring could translate into major advantages for clinicians, hospitals and patients: ease of usage and availability, reduced recovery time, and improved patient outcome. Impedance Cardiography (ICG) is a promising noninvasive technology for cardiac output monitoring but available information on the ICG signals is more scare than other physiological signals such as the electrocardiogram (ECG). The present Doctoral Thesis contributes to the development of signal treatment techniques for the ICG in order to create an innovative hemodynamic monitor. First, an extensive literature review is provided regarding the basics of the clinical background in which cardiac output monitoring is used and concerning the state of the art of cardiac output monitors on the market. This Doctoral Thesis has produced a considerable amount of clinical data which is also explained in detail. These clinical data are also useful to complement the theoretical explanation of patient indices such as heart rate variability, blood flow and blood pressure. In addition, a new method to create synthetic biomedical signals with known time-frequency characteristics is introduced. One of the first analysis in this Doctoral Thesis studies the time difference between peak points of the heart beats in the ECG and the ICG: the RC segment. This RC segment is a measure of the time delay between electrical and mechanical activity of the heart. The relationship of the RC segment with blood pressure and heart interval is analyzed. The concordance of beat durations of both the electrocardiogram and the impedance cardiogram is one of the key results to develop new artefact detection algorithms and the RC could also have an impact in describing the hemodynamics of a patient. Time-frequency distributions (TFDs) are also used to characterize how the frequency content in impedance cardiography signals change with time. Since TFDs are calculated using concrete kernels, a new method to select the best kernel by using synthetic signals is presented. Optimized TFDs of ICG signals are then calculated to extract severa! features which are used to discriminate between different anesthesia states in patients undergoing surgery. TFD-derived features are also used to describe the whole surgical operations. Relationships between TFD-derived features are analyzed and prediction models for cardiac output are designed. These prediction models prove that the TFD-derived features are related to the patients' cardiac output. Finally, a validation study for the qCO monitor is presented. The qCO monitor has been designed using sorne of the techniques which are consequence of this Doctoral Thesis. The main outputs of this work have been protected with a patent which has already been filed. As a conclusion, this Doctoral Thesis has produced a considerable amount of clinical data and a variety of analysis and processing techniques of impedance cardiography signals which have been included into commercial medical devices already available on the market.El gasto cardíaco (GC) define el flujo de sangre que llega desde el corazón a los distintos órganos del cuerpo y es, por tanto, un determinante primario del transporte global de oxígeno. Se ha medido tradicionalmente usando métodos invasivos cuyos riesgos excedían en ocasiones las ventajas de su monitorización. En este contexto, la minimización del riesgo de la monitorización del gasto cardíaco en nuevas tecnologías no invasivas podría traducirse en mayores ventajas para médicos, hospitales y pacientes: facilidad de uso, disponibilidad del equipamiento y menor tiempo de recuperación y mejores resultados en el paciente. La impedancio-cardiografía o cardiografía de impedancia (ICG} es una prometedora tecnología no invasiva para la monitorización del gasto cardíaco. Sin embargo, la información disponible sobre las señales de ICG es más escasa que otras señales fisiológicas como el electrocardiograma (ECG). La presente Tesis Doctoral contribuye al desarrollo de técnicas de tratamiento de señal de ICG para así crear un monitor hemodinámico innovador. En primer lugar, se proporciona una extensa revisión bibliográfica sobre los aspectos básicos del contexto clínico en el que se utiliza la monitorización del gasto cardíaco así como sobre el estado del arte de los monitores de gasto cardíaco que existen en el mercado. Esta Tesis Doctoral ha producido una considerable cantidad de datos clínicos que también se explican en detalle. Dichos datos clínicos también son útiles para complementar las explicaciones teóricas de los índices de paciente de variabilidad cardíaca y el flujo y la presión sanguíneos. Además, se presenta un nuevo método de creación de señales sintéticas biomédicas con características de tiempo-frecuencia conocidas. Uno de los primeros análisis de esta Tesis Doctoral estudia la diferencia temporal entre los picos de los latidos cardíacos del ECG y del ICG: el segmento RC. Este segmento RC es una medida del retardo temporal entre la actividad eléctrica y mecánica del corazón. Se analiza la relación del segmento RC con la presión arterial y el intervalo cardíaco. La concordancia entre la duración de los latidos del ECG y del ICG es uno de los resultados claves para desarrollar nuevos algoritmos de detección de artefactos y el segmento RC también podría ser relevante en la descripción de la hemodinámica de los pacientes. Las distribuciones de tiempo-frecuencia (TFD, por sus siglas en inglés) se utilizan para caracterizar cómo el contenido de las señales de impedancia cardiográfica cambia con el tiempo. Dado que las TFDs deben calcularse usando núcleos (kernels, en inglés) concretos, se presenta un nuevo método para seleccionar el mejor núcleo mediante el uso de señales sintéticas. Las TFDs de ICG optimizadas se calculan para extraer distintas características que son usadas para discriminar entre los diferentes estados de anestesia en pacientes sometidos a procesos quirúrgicos. Las características derivadas de las distribuciones de tiempo-frecuencia también son utilizadas para describir las operaciones quirúrgicas durante toda su extensión temporal. La relación entre dichas características son analizadas y se proponen distintos modelos de predicción para el gasto cardíaco. Estos modelos de predicción demuestran que las características derivadas de las distribuciones tiempo-frecuencia de señales de ICG están relacionadas con el gasto cardíaco de los pacientes. Finalmente, se presenta un estudio de validación del monitor qCO, diseñado con alguna de las técnicas que son consecuencia de esta Tesis Doctoral. Las principales conclusiones de este trabajo han sido protegidas con una patente que ya ha sido registrada. Como conclusión, esta Tesis Doctoral ha producido una considerable cantidad de datos clínicos y una variedad de técnicas de procesado y análisis de señales de cardiografía de impedancia que han sido incluidas en dispositivos biomédicos disponibles en el mercad

Advanced bioimpedance signal processing techniques for hemodynamic monitoring during anesthesia

Aplicat embargament des de la data de defensa fins els maig 2020.Cardiac output (CO) defines the blood flow arriving from the heart to the different organs in the body and it is thus a primary determinant of global 02 transport. Cardiac output has traditionally been measured using invasive methods, whose risk sometimes exceeds the advantages of a cardiac output monitoring. In this context, the minimization of risk in new noninvasive technologies for CO monitoring could translate into major advantages for clinicians, hospitals and patients: ease of usage and availability, reduced recovery time, and improved patient outcome. Impedance Cardiography (ICG) is a promising noninvasive technology for cardiac output monitoring but available information on the ICG signals is more scare than other physiological signals such as the electrocardiogram (ECG). The present Doctoral Thesis contributes to the development of signal treatment techniques for the ICG in order to create an innovative hemodynamic monitor. First, an extensive literature review is provided regarding the basics of the clinical background in which cardiac output monitoring is used and concerning the state of the art of cardiac output monitors on the market. This Doctoral Thesis has produced a considerable amount of clinical data which is also explained in detail. These clinical data are also useful to complement the theoretical explanation of patient indices such as heart rate variability, blood flow and blood pressure. In addition, a new method to create synthetic biomedical signals with known time-frequency characteristics is introduced. One of the first analysis in this Doctoral Thesis studies the time difference between peak points of the heart beats in the ECG and the ICG: the RC segment. This RC segment is a measure of the time delay between electrical and mechanical activity of the heart. The relationship of the RC segment with blood pressure and heart interval is analyzed. The concordance of beat durations of both the electrocardiogram and the impedance cardiogram is one of the key results to develop new artefact detection algorithms and the RC could also have an impact in describing the hemodynamics of a patient. Time-frequency distributions (TFDs) are also used to characterize how the frequency content in impedance cardiography signals change with time. Since TFDs are calculated using concrete kernels, a new method to select the best kernel by using synthetic signals is presented. Optimized TFDs of ICG signals are then calculated to extract severa! features which are used to discriminate between different anesthesia states in patients undergoing surgery. TFD-derived features are also used to describe the whole surgical operations. Relationships between TFD-derived features are analyzed and prediction models for cardiac output are designed. These prediction models prove that the TFD-derived features are related to the patients' cardiac output. Finally, a validation study for the qCO monitor is presented. The qCO monitor has been designed using sorne of the techniques which are consequence of this Doctoral Thesis. The main outputs of this work have been protected with a patent which has already been filed. As a conclusion, this Doctoral Thesis has produced a considerable amount of clinical data and a variety of analysis and processing techniques of impedance cardiography signals which have been included into commercial medical devices already available on the market.El gasto cardíaco (GC) define el flujo de sangre que llega desde el corazón a los distintos órganos del cuerpo y es, por tanto, un determinante primario del transporte global de oxígeno. Se ha medido tradicionalmente usando métodos invasivos cuyos riesgos excedían en ocasiones las ventajas de su monitorización. En este contexto, la minimización del riesgo de la monitorización del gasto cardíaco en nuevas tecnologías no invasivas podría traducirse en mayores ventajas para médicos, hospitales y pacientes: facilidad de uso, disponibilidad del equipamiento y menor tiempo de recuperación y mejores resultados en el paciente. La impedancio-cardiografía o cardiografía de impedancia (ICG} es una prometedora tecnología no invasiva para la monitorización del gasto cardíaco. Sin embargo, la información disponible sobre las señales de ICG es más escasa que otras señales fisiológicas como el electrocardiograma (ECG). La presente Tesis Doctoral contribuye al desarrollo de técnicas de tratamiento de señal de ICG para así crear un monitor hemodinámico innovador. En primer lugar, se proporciona una extensa revisión bibliográfica sobre los aspectos básicos del contexto clínico en el que se utiliza la monitorización del gasto cardíaco así como sobre el estado del arte de los monitores de gasto cardíaco que existen en el mercado. Esta Tesis Doctoral ha producido una considerable cantidad de datos clínicos que también se explican en detalle. Dichos datos clínicos también son útiles para complementar las explicaciones teóricas de los índices de paciente de variabilidad cardíaca y el flujo y la presión sanguíneos. Además, se presenta un nuevo método de creación de señales sintéticas biomédicas con características de tiempo-frecuencia conocidas. Uno de los primeros análisis de esta Tesis Doctoral estudia la diferencia temporal entre los picos de los latidos cardíacos del ECG y del ICG: el segmento RC. Este segmento RC es una medida del retardo temporal entre la actividad eléctrica y mecánica del corazón. Se analiza la relación del segmento RC con la presión arterial y el intervalo cardíaco. La concordancia entre la duración de los latidos del ECG y del ICG es uno de los resultados claves para desarrollar nuevos algoritmos de detección de artefactos y el segmento RC también podría ser relevante en la descripción de la hemodinámica de los pacientes. Las distribuciones de tiempo-frecuencia (TFD, por sus siglas en inglés) se utilizan para caracterizar cómo el contenido de las señales de impedancia cardiográfica cambia con el tiempo. Dado que las TFDs deben calcularse usando núcleos (kernels, en inglés) concretos, se presenta un nuevo método para seleccionar el mejor núcleo mediante el uso de señales sintéticas. Las TFDs de ICG optimizadas se calculan para extraer distintas características que son usadas para discriminar entre los diferentes estados de anestesia en pacientes sometidos a procesos quirúrgicos. Las características derivadas de las distribuciones de tiempo-frecuencia también son utilizadas para describir las operaciones quirúrgicas durante toda su extensión temporal. La relación entre dichas características son analizadas y se proponen distintos modelos de predicción para el gasto cardíaco. Estos modelos de predicción demuestran que las características derivadas de las distribuciones tiempo-frecuencia de señales de ICG están relacionadas con el gasto cardíaco de los pacientes. Finalmente, se presenta un estudio de validación del monitor qCO, diseñado con alguna de las técnicas que son consecuencia de esta Tesis Doctoral. Las principales conclusiones de este trabajo han sido protegidas con una patente que ya ha sido registrada. Como conclusión, esta Tesis Doctoral ha producido una considerable cantidad de datos clínicos y una variedad de técnicas de procesado y análisis de señales de cardiografía de impedancia que han sido incluidas en dispositivos biomédicos disponibles en el mercadoPostprint (published version

Multidimensional embedded MEMS motion detectors for wearable mechanocardiography and 4D medical imaging

Background: Cardiovascular diseases are the number one cause of death. Of these deaths, almost 80% are due to coronary artery disease (CAD) and cerebrovascular disease. Multidimensional microelectromechanical systems (MEMS) sensors allow measuring the mechanical movement of the heart muscle offering an entirely new and innovative solution to evaluate cardiac rhythm and function. Recent advances in miniaturized motion sensors present an exciting opportunity to study novel device-driven and functional motion detection systems in the areas of both cardiac monitoring and biomedical imaging, for example, in computed tomography (CT) and positron emission tomography (PET). Methods: This Ph.D. work describes a new cardiac motion detection paradigm and measurement technology based on multimodal measuring tools — by tracking the heart’s kinetic activity using micro-sized MEMS sensors — and novel computational approaches — by deploying signal processing and machine learning techniques—for detecting cardiac pathological disorders. In particular, this study focuses on the capability of joint gyrocardiography (GCG) and seismocardiography (SCG) techniques that constitute the mechanocardiography (MCG) concept representing the mechanical characteristics of the cardiac precordial surface vibrations. Results: Experimental analyses showed that integrating multisource sensory data resulted in precise estimation of heart rate with an accuracy of 99% (healthy, n=29), detection of heart arrhythmia (n=435) with an accuracy of 95-97%, ischemic disease indication with approximately 75% accuracy (n=22), as well as significantly improved quality of four-dimensional (4D) cardiac PET images by eliminating motion related inaccuracies using MEMS dual gating approach. Tissue Doppler imaging (TDI) analysis of GCG (healthy, n=9) showed promising results for measuring the cardiac timing intervals and myocardial deformation changes. Conclusion: The findings of this study demonstrate clinical potential of MEMS motion sensors in cardiology that may facilitate in time diagnosis of cardiac abnormalities. Multidimensional MCG can effectively contribute to detecting atrial fibrillation (AFib), myocardial infarction (MI), and CAD. Additionally, MEMS motion sensing improves the reliability and quality of cardiac PET imaging.Moniulotteisten sulautettujen MEMS-liiketunnistimien käyttö sydänkardiografiassa sekä lääketieteellisessä 4D-kuvantamisessa Tausta: Sydän- ja verisuonitaudit ovat yleisin kuolinsyy. Näistä kuolemantapauksista lähes 80% johtuu sepelvaltimotaudista (CAD) ja aivoverenkierron häiriöistä. Moniulotteiset mikroelektromekaaniset järjestelmät (MEMS) mahdollistavat sydänlihaksen mekaanisen liikkeen mittaamisen, mikä puolestaan tarjoaa täysin uudenlaisen ja innovatiivisen ratkaisun sydämen rytmin ja toiminnan arvioimiseksi. Viimeaikaiset teknologiset edistysaskeleet mahdollistavat uusien pienikokoisten liiketunnistusjärjestelmien käyttämisen sydämen toiminnan tutkimuksessa sekä lääketieteellisen kuvantamisen, kuten esimerkiksi tietokonetomografian (CT) ja positroniemissiotomografian (PET), tarkkuuden parantamisessa. Menetelmät: Tämä väitöskirjatyö esittelee uuden sydämen kineettisen toiminnan mittaustekniikan, joka pohjautuu MEMS-anturien käyttöön. Uudet laskennalliset lähestymistavat, jotka perustuvat signaalinkäsittelyyn ja koneoppimiseen, mahdollistavat sydämen patologisten häiriöiden havaitsemisen MEMS-antureista saatavista signaaleista. Tässä tutkimuksessa keskitytään erityisesti mekanokardiografiaan (MCG), joihin kuuluvat gyrokardiografia (GCG) ja seismokardiografia (SCG). Näiden tekniikoiden avulla voidaan mitata kardiorespiratorisen järjestelmän mekaanisia ominaisuuksia. Tulokset: Kokeelliset analyysit osoittivat, että integroimalla usean sensorin dataa voidaan mitata syketiheyttä 99% (terveillä n=29) tarkkuudella, havaita sydämen rytmihäiriöt (n=435) 95-97%, tarkkuudella, sekä havaita iskeeminen sairaus noin 75% tarkkuudella (n=22). Lisäksi MEMS-kaksoistahdistuksen avulla voidaan parantaa sydämen 4D PET-kuvan laatua, kun liikeepätarkkuudet voidaan eliminoida paremmin. Doppler-kuvantamisessa (TDI, Tissue Doppler Imaging) GCG-analyysi (terveillä, n=9) osoitti lupaavia tuloksia sydänsykkeen ajoituksen ja intervallien sekä sydänlihasmuutosten mittaamisessa. Päätelmä: Tämän tutkimuksen tulokset osoittavat, että kardiologisilla MEMS-liikeantureilla on kliinistä potentiaalia sydämen toiminnallisten poikkeavuuksien diagnostisoinnissa. Moniuloitteinen MCG voi edistää eteisvärinän (AFib), sydäninfarktin (MI) ja CAD:n havaitsemista. Lisäksi MEMS-liiketunnistus parantaa sydämen PET-kuvantamisen luotettavuutta ja laatua

Advancements and Breakthroughs in Ultrasound Imaging

Ultrasonic imaging is a powerful diagnostic tool available to medical practitioners, engineers and researchers today. Due to the relative safety, and the non-invasive nature, ultrasonic imaging has become one of the most rapidly advancing technologies. These rapid advances are directly related to the parallel advancements in electronics, computing, and transducer technology together with sophisticated signal processing techniques. This book focuses on state of the art developments in ultrasonic imaging applications and underlying technologies presented by leading practitioners and researchers from many parts of the world

Non-invasive hemodynamic monitoring by electrical impedance tomography

The monitoring of central hemodynamic parameters such as cardiac output (CO) and pulmonary artery pressure (PAP) is of paramount clinical importance to assess the health status of the cardiovascular system. However, their measurement requires the insertion of a pulmonary artery catheter, a highly invasive procedure associated with non-negligible morbidity and mortality rates. In this thesis, we investigated the clinical potential of electrical impedance tomography (EIT) - a radiation-free medical imaging technique - as a non-invasive alternative for the measurement of CO and PAP. In a first phase, we investigated the potential of EIT for the measurement of CO. This measurement is implicitly based on the hypothesis that the EIT heart signal (the ventricular component of the EIT signals) is induced by ventricular blood volume changes. This hypothesis has never been formally investigated, and the exact origins of the EIT heart signal remain subject to interpretation. Therefore, using a model, we investigated the genesis of this signal by identifying its various sources and their respective contributions. The results revealed that the EIT heart signal is dominated by cardioballistic effects (heart motion). However, although of prominently cardioballistic origin, the amplitude of the signal has shown to be strongly correlated to stroke volume (r = 0.996, p < 0.001; error of 0.57 +/- 2.19 mL). We explained these observations by the quasi-incompressibility of myocardial tissue and blood. We further identified several factors and conditions susceptible to affect the accuracy of the measurement. Finally, we investigated the influence of the EIT sensor belt position on the measured heart signal. We observed that small belt displacements - likely to occur in clinical settings during patient handling - can induce errors of up to 30 mL on stroke volume estimation. In a second phase, we investigated the feasibility of a novel method for the non-invasive measurement of PAP by EIT. The method is based on the physiological relation linking the PAP to the velocity of propagation of the pressure waves in the pulmonary arteries. We hypothesized that the variations of this velocity, and therefore of the PAP, could be measured by EIT. In a bioimpedance model of the human thorax, we demonstrated the feasibility of our method in various types of pulmonary hypertensive disorders. Our EIT-derived parameter has shown to be particularly well-suited for predicting early changes in pulmonary hemodynamics due to its physiological link with arterial compliance. Finally, we validated experimentally our method in 14 subjects undergoing hypoxia-induced PAP changes. Significant correlation coefficients (range: [0.70, 0.98], average: 0.89) and small standard errors of the estimate (range: [0.9, 6.3] mmHg, average: 2.4 mmHg) were found between our EIT-derived systolic PAP and reference systolic PAP values obtained by Doppler echocardiography. In conclusion, there is a promising outlook for EIT in non-invasive hemodynamic monitoring. Our observations provide novel insights for the interpretation and understanding of EIT heart signals, and detail the physiological and metrological requirements for an accurate measurement of CO by EIT. Our novel PAP monitoring method, validated in vivo, allows a reliable tracking of PAP changes, thereby paving the way towards the development of a new branch of non-invasive hemodynamic monitors based on the use of EIT